TCR2 Therapeutics Inc. buy Global_Player
Start price
18.09.22
/
50%
€2.22
Target price
18.09.23
-
Performance (%)
-14.79%
End price
01.10.22
€1.89
Summary
This prediction ended on 01.10.22 with a price of €1.89. The price of TCR2 Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.79%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by Global_Player for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy TCR2 Therapeutics Inc.